Showing 1 - 20 results of 168 for search '"панкреатодуоденальная резекция"', query time: 0.85s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
    Academic Journal

    Source: Siberian journal of oncology; Том 23, № 2 (2024); 82-91 ; Сибирский онкологический журнал; Том 23, № 2 (2024); 82-91 ; 2312-3168 ; 1814-4861

    File Description: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/3040/1218; Changazi S.H., Ahmed Q., Bhatti S., Siddique S., Abdul Raffay E., Farooka M.W., Ayyaz M. Whipple Procedure: A Five-Year Clinical Experience in Tertiary Care Center. Cureus. 2020; 12(11). doi:10.7759/cureus.11466.; Pugalenthi A., Protic M., Gonen M., Kingham T.P., Angelica M.I., Dematteo R.P., Fong Y., Jarnagin W.R., Allen P.J. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol. 2016; 113(2): 188–93. doi:10.1002/jso.24125.; Are C., Dhir M., Ravipati L. History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers. HPB (Oxford). 2011; 13(6): 377–84. doi:10.1111/j.1477-2574.2011.00305.x.; Котельников А.Г., Патютко Ю.И., Подлужный Д.В., Саакян М.С., Кушлинский Н.Е., Любимова Н.В., Тимофеев Ю.С., Шахбазян Р.Г., Поляков А.Н., Кудашкин Н.Е., Тихонов П.А., Стилиди И.С. Функциональные результаты панкреатодуоденальной резекции. Анналы хирургической гепатологии. 2023; 28(1): 71–9. doi:10.16931/1995-5464.2023-1-71-79.; Котельников А.Г., Патютко Ю.И., Подлужный Д.В., Саакян М.С., Кудашкин Н.Е., Поляков А.Н., Тихонов П.А., Сулейманов Э.А., Стилиди И.С. Панкреатодигестивный анастомоз – ключ к благоприятному исходу панкреатодуоденальной резекции. Анналы хирургической гепатологии. 2022; 27(3): 92–9. doi:10.16931/1995-5464.2022-3-92-99.; Moole H., Bechtold M., Puli S.R. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. World J Surg Oncol. 2016; 14(1): 182. doi:10.1186/s12957-016-0933-2.; van der Gaag N.A., Rauws E.A., van Eijck C.H., Bruno M.J., van der Harst E., Kubben F.J., Gerritsen J.J., Greve J.W., Gerhards M.F., de Hingh I.H., Klinkenbijl J.H., Nio C.Y., de Castro S.M., Busch O.R., van Gulik T.M., Bossuyt P.M., Gouma D.J. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010; 362(2): 129–37. doi:10.1056/NEJMoa0903230.; Li Z., Zhang Z., Hu W., Zeng Y., Liu X., Mai G., Zhang Y., Lu H., Tian B. Pancreaticoduodenectomy with preoperative obstructive jaundice: drainage or not. Pancreas. 2009; 38(4): 379–86. doi:10.1097/MPA.0b013e31819f638b.; Gao Z., Wang J., Shen S., Bo X., Suo T., Ni X., Liu H., Huang L., Liu H. The impact of preoperative biliary drainage on postoperative outcomes in patients with malignant obstructive jaundice: a retrospective analysis of 290 consecutive cases at a single medical center. World J Surg Oncol. 2022; 20(1): 7. doi:10.1186/s12957-021-02476-z.; Pattarapuntakul T., Charoenrit T., Netinatsunton N., Yaowmaneerat T., Pitakteerabundit T., Ovartlarnporn B., Attasaranya S., Wong T., Chamroonkul N., Sripongpun P. Postoperative outcomes of resectable periampullary cancer accompanied by obstructive jaundice with and without preoperative endoscopic biliary drainage. Front Oncol. 2022; 12. doi:10.3389/fonc.2022.1040508.; Zhu L., Yang Y., Cheng H., Cai Z., Tang N., Mao L., Fu X., Qiu Y. The role of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy in patients with obstructive jaundice. Gland Surg. 2023; 12(5): 593–608. doi:10.21037/gs-22-648.; Satoh D., Matsukawa H., Shiozaki S. The Optimal Type and Management of Biliary Drainage in Patients With Obstructive Jaundice Who Undergo Pancreaticoduodenectomy. In Vivo. 2022; 36(1): 391–7. doi:10.21873/invivo.12716.; Патютко Ю.И., Кудашкин Н.Е., Котельников А.Г., Абгарян М.Г. Гастропанкреатодуоденальная резекция при злокачественных заболеваниях, осложненных механической желтухой. Хирургия. Журнал им. Н.И. Пирогова. 2011; (2): 25–32.; Duan F., Cui L., Bai Y., Li X., Yan J., Liu X. Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: a systematic review and meta-analysis. Cancer Imaging. 2017; 17(1): 27. doi:10.1186/s40644-017-0129-1.; Yin T., Qin T., Wei K., Shen M., Zhang Z., Wen J., Pan S., Guo X., Zhu F., Wang M., Zhang H., Hilal M.A., Qin R. Comparison of safety and effectiveness between laparoscopic and open pancreatoduodenectomy: A systematic review and meta-analysis. Int J Surg. 2022; 105. doi:10.1016/j.ijsu.2022.106799.; Russell T.B., Aroori S. Procedure-specific morbidity of pancreatoduodenectomy: a systematic review of incidence and risk factors. ANZ J Surg. 2022; 92(6): 1347–55. doi:10.1111/ans.17473.; Dominguez O.H., Grigorian A., Wolf R.F., Imagawa D.K., Nahmias J.T., Jutric Z. Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma. Updates Surg. 2023; 75(3): 523–30. doi:10.1007/s13304-022-01404-4.; Williamsson C., Stenvall K., Wennerblom J., Andersson R., Andersson B., Tingstedt B. Predictive Factors for Postoperative Pancreatic Fistula-A Swedish Nationwide Register-Based Study. World J Surg. 2020;44(12): 4207–13. doi:10.1007/s00268-020-05735-4.; Ellis R.J., Brock Hewitt D., Liu J.B., Cohen M.E., Merkow R.P., Bentrem D.J., Bilimoria K.Y., Yang A.D. Preoperative risk evaluation for pancreatic fistula after pancreaticoduodenectomy. J Surg Oncol. 2019;119(8): 1128–34. doi:10.1002/jso.25464.; Jin J., Xiong G., Li J., Guo X., Wang M., Li Z., Zhu F., Qin R. Predictive factors of postoperative pancreatic fistula after laparoscopic pancreatoduodenectomy. Ann Transl Med. 2021; 9(1): 41. doi:10.21037/atm-20-1411.; Andrianello S., Marchegiani G., Malleo G., Pollini T., Bonamini D., Salvia R., Bassi C., Landoni L. Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies. HPB (Oxford). 2017; 19(3): 264–9. doi:10.1016/j.hpb.2016.11.011.; Malgras B., Duron S., Gaujoux S., Dokmak S., Aussilhou B., Rebours V., Palazzo M., Belghiti J., Sauvanet A. Early biliary complications following pancreaticoduodenectomy: prevalence and risk factors. HPB (Oxford). 2016; 18(4): 367–74. doi:10.1016/j.hpb.2015.10.012.; El NakeebA., El Sorogy M., Hamed H., Said R., Elrefai M., Ezzat H., Askar W., Elsabbagh A.M. Biliary leakage following pancreaticoduodenectomy: Prevalence, risk factors and management. Hepatobiliary Pancreat Dis Int. 2019; 18(1): 67–72. doi:10.1016/j.hbpd.2018.10.005.; Mazza M., Crippa S., Pecorelli N., Tamburino D., Partelli S., Castoldi R., Balzano G., Falconi M. Duodeno-jejunal or gastro-enteric leakage after pancreatic resection: a case-control study. Updates Surg. 2019; 71(2): 295–303. doi:10.1007/s13304-019-00637-0.; Gungor F., Babayev A., Onak C., Acar T., Bag H., Kar H., Dilek O. Mortality after pancreaticoduodenectomy: Single center outcomes. HPB. 2020; 22s2: 302. doi:10.1016/j.hpb.2020.04.250.; Gao F., Li J., Quan S., Li F., Ma D., Yao L., Zhang P. Risk Factors and Treatment for Hemorrhage after Pancreaticoduodenectomy: A Case Series of 423 Patients. Biomed Res Int. 2016. doi:10.1155/2016/2815693.; Kasumova G.G., Eskander M.F., Kent T.S., Ng S.C., Moser A.J., Ahmed M., Pleskow D.K., Callery M.P., Tseng J.F. Hemorrhage after pancreaticoduodenectomy: does timing matter? HPB (Oxford). 2016; 18(10):861–9. doi:10.1016/j.hpb.2016.07.001.; Grace P.A., Pitt H.A., Tompkins R.K., DenBesten L., Longmire W.P. Jr. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg. 1986; 151(1): 141–9. doi:10.1016/0002-9610(86)90024-3.; Crist D.W., Sitzmann J.V., Cameron J.L. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987;206(3): 358–65. doi:10.1097/00000658-198709000-00014.; Narayanan S., Martin A.N., Turrentine F.E., Bauer T.W., Adams R.B., Zaydfudim V.M. Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death. J Surg Res. 2018; 231:304–8. doi:10.1016/j.jss.2018.05.075.; Lessing Y., Pencovich N., Nevo N., Lubezky N., Goykhman Y., Nakache R., Lahat G., Klausner J.M., Nachmany I. Early reoperation following pancreaticoduodenectomy: impact on morbidity, mortality, and long-term survival. World J Surg Oncol. 2019; 17(1): 26. doi:10.1186/s12957-019-1569-9.; Sugimoto M., Takahashi S., Kojima M., Kobayashi T., Gotohda N., Konishi M. In Patients with a Soft Pancreas, a Thick Parenchyma, a Small Duct, and Fatty Infiltration Are Significant Risks for Pancreatic Fistula After Pancreaticoduodenectomy. J Gastrointest Surg. 2017; 21(5): 846–54. doi:10.1007/s11605-017-3356-7.; Schuh F., Mihaljevic A.L., Probst P., Trudeau M.T., Müller P.C., Marchegiani G., Besselink M.G., Uzunoglu F., Izbicki J.R., Falconi M., Castillo C.F., Adham M., Z’graggen K., Friess H., Werner J., Weitz J., Strobel O., Hackert T., Radenkovic D., Kelemen D., Wolfgang C., Miao Y.I., Shrikhande S.V., Lillemoe K.D., Dervenis C., Bassi C., Neoptolemos J.P., Diener M.K., Vollmer C.M. Jr, Büchler M.W. A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: Aclassification of the International Study Group of Pancreatic Surgery.Ann Surg. 2023; 277(3): 597–608. doi:10.1097/SLA.0000000000004855.; Dei H., Natsume S., Okuno M., Kawakatsu S., Hosoda W., Matsuo K., Hara K., Ito S., Komori K., Abe T., Nagino M., Shimizu Y. Impact of pancreatic fat infiltration on postoperative pancreatic fistula occurrence in patients undergoing invagination pancreaticojejunostomy. HPB (Oxford). 2022; 24(12): 2119–24. doi:10.1016/j.hpb.2022.08.013.; Lee K.F., Wong K.K.C., Lo E.Y.J., Kung J.W.C., Lok H.T., Chong C.C.N., Wong J., Lai P.B.S., Ng K.K.C. What is the pancreatic duct size limit for a safe duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy? A retrospective study. Ann Hepatobiliary Pancreat Surg. 2022; 26(1): 84–90. doi:10.14701/ahbps.21-054.; Tewari M., Mahendran R., Kiran T., Verma A., Dixit V.K., Shukla S., Shukla H.S. Outcome of 150 Consecutive Blumgart’s Pancreaticojejunostomy After Pancreaticoduodenectomy. Indian J Surg Oncol. 2019; 10(1): 65–71. doi:10.1007/s13193-018-0821-z.; Yeo C.J., Cameron J.L., Lillemoe K.D., Sitzmann J.V., Hruban R.H., Goodman S.N., Dooley W.C., Coleman J., Pitt H.A. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995; 221(6): 721–31; discussion 731–3. doi:10.1097/00000658-199506000-00011.; Zimmitti G., Coppola A., Ardito F., Meniconi R., Ettorre G.M., Rosso E., Manzoni A., Colasanti M., Clemente G., Murazio M., Giuliante F. Outcomes comparison of Pancreato-Gastrostomy and Isolated Jejunal Loop Pancreato-Jejunostomy following Pancreato-Duodenectomy in patients with soft pancreas and at moderate-high risk for POPF: a retrospective multicenter experience-based analysis. Updates Surg. 2022; 74(1): 223–34. doi:10.1007/s13304-021-01203-3.; Cao Z., Luo W., Qiu J., Liu Y., Zheng L., Zhang T. Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis. Front Oncol. 2020; 10: 1637. doi:10.3389/fonc.2020.01637.; Kakita A., Takahashi T., Yoshida M., Furuta K. A simpler and more reliable technique of pancreatojejunal anastomosis. Surg Today. 1996;26(7): 532–5. doi:10.1007/BF00311562.; Ma D., Du G., Yang J., Song J., Ma H., Wang J., Zhang T., Jin B. Clinical Application of a Modified Double Purse-String Continuous Suture Technique for Pancreaticojejunostomy: Reliable for Laparoscopic Surgery and Small Size Main Pancreatic Duct. Biomed Res Int. 2021. doi:10.1155/2021/6676999.; ZhaoA., Zhu Q., Qin X., Wang K., Tan K., Liu Z., Song W., Cheng Q., Li X., Chen Z., Liu Z., Yuan Y., Yang Z. A duct-to-mucosa pancreaticoje-junostomy for small main pancreatic duct and soft pancreas in minimally invasive pancreaticoduodenectomy. Surg Endosc. 2023; 37(5): 3567–79. doi:10.1007/s00464-022-09830-6.; Markar S.R., Vyas S., Karthikesalingam A., Imber C., Malago M. The impact of pancreatic duct drainage following pancreaticojejunostomy on clinical outcome. J Gastrointest Surg. 2012; 16(8): 1610–7. doi:10.1007/s11605-012-1852-3.; Gurram R.P., S L H., Gnanasekaran S., Choudhury S.R., Pottakkat B., Raja K. External pancreatic ductal stenting in minimally invasive pancreatoduodenectomy: How to do it? Ann Hepatobiliary Pancreat Surg. 2023; 27(2): 211–6. doi:10.14701/ahbps.22-098.; Guo C., Xie B., Guo D. Does pancreatic duct stent placement lead to decreased postoperative pancreatic fistula rates after pancreaticoduodenectomy? A meta-analysis. Int J Surg. 2022; 103. doi:10.1016/j.ijsu.2022.106707.; Nikhil S., Halder P.J., Santhosh R., Ravindra N. Does the Anatomy of the Transected Pancreatic Neck Influence Post Whipple’s Operation Pancreatic Fistula? Indian J Surg Oncol. 2019; 10(1): 31–6. doi:10.1007/s13193-018-0747-5.; Ridolfi C., Angiolini M.R., Gavazzi F., Spaggiari P., Tinti M.C., Uccelli F., Madonini M., Montorsi M., Zerbi A. Morphohistological features of pancreatic stump are the main determinant of pancreatic fistula after pancreatoduodenectomy. Biomed Res Int. 2014. doi:10.1155/2014/641239.; Kazantsev G.B., SpitzerA.L., Peng P.D., Ramirez R.M., Chang C.K., Tsai S., Aldakkak M., Huyser M.R., Dominguez D.A. Pancreaticogastrostomy as a fistula mitigating strategy for a high-risk pancreatic anastomosis following pancreaticoduodenectomy. HPB (Oxford). 2023; 25(1): 124–35. doi:10.1016/j.hpb.2022.10.003.; Lassen K., Coolsen M.M., Slim K., Carli F., de Aguilar-Nascimento J.E., Schäfer M., Parks R.W., Fearon K.C., Lobo D.N., Demartines N., Braga M., Ljungqvist O., Dejong C.H.; Enhanced Recovery After Surgery (ERAS) Society, for Perioperative Care; European Society for Clinical Nutrition and Metabolism (ESPEN); International Association for Surgical Metabolism and Nutrition (IASMEN). Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. World J Surg. 2013; 37(2): 240–58. doi:10.1007/s00268-012-1771-1.; Kuemmerli C., Tschuor C., Kasai M., Alseidi A.A., Balzano G., Bouwense S., Braga M., Coolsen M., Daniel S.K., Dervenis C., Falconi M., Hwang D.W., Kagedan D.J., Kim S.C., Lavu H., Liang T., Nussbaum D., Partelli S., Passeri M.J., Pecorelli N., Pillai S.A., Pillarisetty V.G., Pucci M.J., Su W., Sutcliffe R.P., Tingstedt B., van der Kolk M., Vrochides D., Wei A., Williamsson C., Yeo C.J., Zani S., Zouros E., Abu Hilal M. Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis. Br J Surg. 2022; 109(3): 256–66. doi:10.1093/bjs/znab436.; Prabhakaran S., Doraiswamy V.A., Nagaraja V., Cipolla J., Ofurum U., Evans D.C., Lindsey D.E., Seamon M.J., Kavuturu S., Gerlach A.T., Jaik N.P., Eiferman D.S., Papadimos T.J., Adolph M.D., Cook C.H., Stawicki S.P. Nasoenteric tube complications. Scand J Surg. 2012; 101(3):147–55. doi:10.1177/145749691210100302. Erratum in: Scand J Surg. 2013; 102(3): 215.; Yin J., Lu Z., Wu P., Wu J., Gao W., Wei J., Guo F., Chen J., Jiang K., Miao Y. Afferent Loop Decompression Technique is Associated with a Reduction in Pancreatic Fistula Following Pancreaticoduodenectomy. World J Surg. 2018; 42(11): 3726–35. doi:10.1007/s00268-018-4679-6.; Gianotti L., Besselink M.G., Sandini M., Hackert T., Conlon K., Gerritsen A., Griffin O., Fingerhut A., Probst P., Abu Hilal M., Marchegiani G., Nappo G., Zerbi A., Amodio A., Perinel J., Adham M., Raimondo M., Asbun H.J., Sato A., Takaori K., Shrikhande S.V., DelChiaro M., Bockhorn M., Izbicki J.R., Dervenis C., Charnley R.M., Martignoni M.E., Friess H., de Pretis N., Radenkovic D., Montorsi M., Sarr M.G., Vollmer C.M., Frulloni L., Büchler M.W., Bassi C. Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2018; 164(5): 1035–48. doi:10.1016/j.surg.2018.05.040.; Klek S., Sierzega M., Turczynowski L., Szybinski P., Szczepanek K., Kulig J. Enteral and parenteral nutrition in the conservative treatment of pancreatic fistula: a randomized clinical trial. Gastroenterology. 2011;141(1): 157–63, 163. doi:10.1053/j.gastro.2011.03.040.; Bozzetti F., Braga M., Gianotti L., Gavazzi C., Mariani L. Post-operative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet. 2001;358(9292): 1487–92. doi:10.1016/S0140-6736(01)06578-3.; Halle-Smith J.M., Pande R., Powell-Brett S., Pathak S., Pandanaboyana S., Smith A.M., Roberts K.J. Early oral feeding after pancreatoduodenectomy: a systematic review and meta-analysis. HPB (Oxford). 2022; 24(10): 1615–21. doi:10.1016/j.hpb.2022.04.005.; Bayramov N., Mammadova S. A review of the current ERAS guide-lines for liver resection, liver transplantation and pancreatoduodenectomy. Ann Med Surg (Lond). 2022; 82. doi:10.1016/j.amsu.2022.104596.; Lassen K., Kjaeve J., Fetveit T., Tranø G., Sigurdsson H.K., Horn A., Revhaug A. Allowing normal food at will after major upper gastrointestinal surgery does not increase morbidity: a randomized multicenter trial. Ann Surg. 2008; 247(5): 721–9. doi:10.1097/SLA.0b013e31815cca68.; Wang S.Y., Hung Y.L., Hsu C.C., Hu C.H., Huang R.Y., Sung C.M., Li Y.R., Kou H.W., Chen M.Y., Chang S.C., Lee C.W., Tsai C.Y., Liu K.H., Hsu J.T., Yeh C.N., Yeh T.S., Hwang T.L., Jan Y.Y., Chen M.F. Optimal Peri-operative Nutrition Therapy for Patients Undergoing Pancreaticoduodenectomy: A Systematic Review with a Component Network Meta-Analysis. Nutrients. 2021; 13(11): 4049. doi:10.3390/nu13114049.; Olakowski M., Grudzińska E. Pancreatic head cancer – Current surgery techniques. Asian J Surg. 2023; 46(1): 73–81. doi:10.1016/j.asjsur.2022.05.117.; Nassour I., Adam M.A., Kowalsky S., Al Masri S., Bahary N., Singhi A.D., Lee K., Zureikat A., Paniccia A. Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies. J Surg Oncol. 2021; 123(1): 245–51. doi:10.1002/jso.26267.; Greco S.H., August D.A., Shah M.M., Chen C., Moore D.F., Masanam M., Turner A.L., Jabbour S.K., Javidian P., Grandhi M.S., Kennedy T.J., Alexander H.R., Carpizo D.R., Langan R.C. Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database. Surg Open Sci. 2020; 3: 22–8. doi:10.1016/j.sopen.2020.12.001.; Cools K.S., Sanoff H.K., Kim H.J., Yeh J.J., Stitzenberg K.B. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy. J Surg Oncol. 2018; 118(3): 455–62. doi:10.1002/jso.25183.; Teng A., Nguyen T., Bilchik A.J., O’Connor V., Lee D.Y. Implications of Prolonged Time to Pancreaticoduodenectomy After Neoadjuvant Chemoradiation. J Surg Res. 2020; 245: 51–6. doi:10.1016/j.jss.2019.07.024.; Tomioka A., Shimizu T., Kagota S., Taniguchi K., Komeda K., Asakuma M., Hirokawa F., Uchiyama K. Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer. Ann Surg Oncol. 2021; 28(7): 3789–97. doi:10.1245/s10434-020-09401-w.; Kamarajah S.K., Bundred J.R., Boyle C., Oo J., Pandanaboyana S., Loveday B. Impact of neoadjuvant therapy on post-operative pancreatic fistula: a systematic review and meta-analysis. ANZ J Surg. 2020; 90(11):2201–10. doi:10.1111/ans.15885.; Zettervall S.L., Ju T., Holzmacher J.L., Rivas L., Lin P.P., Vaziri K. Neoadjuvant Radiation Is Associated with Fistula Formation Following Pancreaticoduodenectomy. J Gastrointest Surg. 2018; 22(6): 1026–33. doi:10.1007/s11605-018-3725-x.; Hyman D.W., Almerey T., Mujkanovic A, Hammons I, Tice M, Stauffer JA. Comparing Post-Operative Outcomes of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Neoadjuvant Therapy Versus Surgery First Approach. Am Surg. 2022; 88(8): 1868–74. doi:10.1177/00031348221087900.; Marchegiani G., Andrianello S., Nessi C., Sandini M., Maggino L., Malleo G., Paiella S., Polati E., Bassi C., Salvia R. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications. Ann Surg Oncol. 2018;25(3): 626–37. doi:10.1245/s10434-017-6281-9.; https://www.siboncoj.ru/jour/article/view/3040

  5. 5
    Academic Journal

    Source: Siberian journal of oncology; Том 23, № 5 (2024); 126-132 ; Сибирский онкологический журнал; Том 23, № 5 (2024); 126-132 ; 2312-3168 ; 1814-4861

    File Description: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/3276/1277; He J., Ahuja N., Makary M.A., Cameron J.L., Eckhauser F.E., Choti M.A., Hruban R.H., Pawlik T.M., Wolfgang C.L. 2564 resected periam pullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014; 16(1): 83–90. doi:10.1111/hpb.12078.; Louvet C., Philip P.A. Accomplishments in 2007 in the treatment of metastatic pancreatic cancer. Gastrointest Cancer Res. 2008; 2(3s): 37–41.; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 7–30. doi:10.3322/caac.21590.; Mayo S.C., de Jong M.C., Pulitano C., Clary B.M., Reddy S.K., Gamblin T.C., Celinksi S.A., Kooby D.A., Staley C.A., Stokes J.B., Chu C.K., Ferrero A., Schulick R.D., Choti M.A., Mentha G., Strub J., Bauer T.W., Adams R.B., Aldrighetti L., Capussotti L., Pawlik T.M. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010; 17(12): 3129–36. doi:10.1245/s10434-010-1154-5.; Ejaz A., Reames B.N., Maithel S., Poultsides G.A., Bauer T.W., Fields R.C., Weiss M.J., Marques H.P., Aldrighetti L., Pawlik T.M. Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis. HPB (Oxford). 2018; 20(3): 277–84. doi:10.1016/j.hpb.2017.08.039.; Conroy T., Desseigne F., Ychou M., Bouché O., Guimbaud R., Bécouarn Y., Adenis A., Raoul J.L., Gourgou-Bourgade S., de la Fouchardière C., Bennouna J., Bachet J.B., KhemissaAkouz F., Péré-Vergé D., Delbaldo C., Assenat E., Chauffert B., Michel P., Montoto-Grillot C., Ducreux M.; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011; 364(19): 1817–25. doi:10.1056/NEJMoa1011923.; Von Hoff D.D., Ervin T., Arena F.P., Chiorean E.G., Infante J., Moore M., Seay T., Tjulandin S.A., Ma W.W., Saleh M.N., Harris M., Reni M., Dowden S., Laheru D., Bahary N., Ramanathan R.K., Tabernero J., Hidalgo M., Goldstein D., van Cutsem E., Wei X., Iglesias J., Renschler M.F. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013; 369(18): 1691–703. doi:10.1056/NEJMoa1304369.; Crippa S., Bittoni A., Sebastiani E., Partelli S., Zanon S., Lanese A., Andrikou K., Muffatti F., Balzano G., Reni M., Cascinu S., Falconi M. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? Eur J Surg Oncol. 2016; 42(10): 1533–9. doi:10.1016/j.ejso.2016.06.398.; Tachezy M., Gebauer F., Janot M., Uhl W., Zerbi A., Montorsi M., Perinel J., Adham M., Dervenis C., Agalianos C., Malleo G., Maggino L., Stein A., Izbicki J.R., Bockhorn M. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surgery. 2016; 160(1): 136–44. doi:10.1016/j.surg.2016.02.019.; Frigerio I., Regi P., Giardino A., Scopelliti F., Girelli R., Bassi C., Gobbo S., Martini P.T., Capelli P., D’Onofrio M., Malleo G., Maggino L., Viviani E., Butturini G. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? Ann Surg Oncol. 2017; 24(8): 2397–403. doi:10.1245/s10434-017-5885-4.; Hellman S., Weichselbaum R.R. Oligometastases. J Clin Oncol. 1995; 13(1): 8–10. doi:10.1200/JCO.1995.13.1.8.; Hackert T., Niesen W., Hinz U., Tjaden C., Strobel O., Ulrich A., Michalski C.W., Büchler M.W. Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol. 2017; 43(2): 358–63. doi:10.1016/j.ejso.2016.10.023.; Wright G.P., Poruk K.E., Zenati M.S., Steve J., Bahary N., Hogg M.E., Zuriekat A.H., Wolfgang C.L., Zeh H.J. 3rd, Weiss M.J. Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-institutional Analysis. J Gastrointest Surg. 2016; 20(11): 1830–5. doi:10.1007/s11605-016-3256-2.; Klein F., Puhl G., Guckelberger O., Pelzer U., Pullankavumkal J.R., Guel S., Neuhaus P., Bahra M. The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma. Gastroenterol Res Pract. 2012. doi:10.1155/2012/939350.; Shi H., Li J., Fu D. Process of hepatic metastasis from pancreatic cancer: biology with clinical signifcance. J Cancer Res Clin Oncol. 2016; 142(6): 1137–61. doi:10.1007/s00432-015-2024-0.; Kajioka H., Kagawa S., Ito A., Yoshimoto M., Sakamoto S., Kikuchi S., Kuroda S., Yoshida R., Umeda Y., Noma K., Tazawa H., Fujiwara T. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Cancer Lett. 2021; 497: 1–13. doi:10.1016/j.canlet.2020.10.015.; Liang C., Qi Z., Ge H., Liang C., Zhang Y., Wang Z., Li R., Guo J. Long non-coding RNA PCAT-1 in human cancers: A meta-analysis. Clin Chim Acta. 2018; 480: 47–55. doi:10.1016/j.cca.2018.01.043.; Buscail L., Bournet B., Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2020; 17(3): 153–68. doi:10.1038/s41575-019-0245-4.; Huo Y., Zhou Y., Zheng J., Jin G., Tao L., Yao H., Zhang J., Sun Y., Liu Y., Hu L.P. GJB3 promotes pancreatic cancer liver metastasis by enhancing the polarization and survival of neutrophil. Front Immunol. 2022; 13. doi:10.3389/fmmu.2022.983116.; Hermann C.D., Schoeps B., Eckfeld C., Munkhbaatar E., Kniep L., Prokopchuk O., Wirges N., Steiger K., Häußler D., Knolle P., Poulton E., Khokha R., Grünwald B.T., Demir I.E., Krüger A. TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. J Exp Med. 2021; 218(11). doi:10.1084/jem.20210911.; Moro L., Pagano M. Epigenetic suppression of FBXL7 promotes metastasis. Mol Cell Oncol. 2020; 7(6). doi:10.1080/23723556.2020.1833698.; Goulart M.R., Watt J., Siddiqui I., Lawlor R.T., Imrali A., Hughes C., Saad A., ChinAleong J., Hurt C., Cox C., Salvia R., Mantovani A., Crnogorac-Jurcevic T., Mukherjee S., Scarpa A., Allavena P., Kocher H.M. Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma. NPJ Precis Oncol. 2021; 5(1): 61. doi:10.1038/s41698-021-00192-1.; Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., Reichert M., Beatty G.L., Rustgi A.K., Vonderheide R.H., Leach S.D., Stanger B.Z. EMT and dissemination precede pancreatic tumor formation. Cell. 2012; 148(1–2): 349–61. doi:10.1016/j.cell.2011.11.025.; Tuveson D.A., Neoptolemos J.P. Understanding metastasis in pancreatic cancer: a call for new clinical approaches. Cell. 2012; 148(1–2): 21–3. doi:10.1016/j.cell.2011.12.021.; Haeno H., Gonen M., Davis M.B., Herman J.M., IacobuzioDonahue C.A., Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012; 148(1–2): 362–75. doi:10.1016/j.cell.2011.11.060.; Addeo P., Oussoultzoglou E., Fuchshuber P., Rosso E., Nobili C., Langella S., Jaeck D., Bachellier P. Safety and outcome of combined liver and pancreatic resections. Br J Surg. 2014; 101(6): 693–700. doi:10.1002/bjs.9443.; Kim Y., Kim S.C., Song K.B., Kim J., Kang D.R., Lee J.H., Park K.M., Lee Y.J. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma. HPB (Oxford). 2016; 18(4): 325–31. doi:10.1016/j.hpb.2015.10.014.; Gebauer F., Damanakis A.I., Popp F., Quaas A., Kütting F., Lutz K., Held S., Deuß B., Göser T., Waldschmidt D., Bruns C. Study protocol of an open-label, single arm phase II trial investigating the efcacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fuorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC). BMC Cancer. 2021; 21(1): 1239. doi:10.1186/s12885-021-08966-3.; Yamanaka M., Hayashi M., Yamada S., Sonohara F., Takami H., Inokawa Y., Shimizu D., Hattori N., Kanda M., Tanaka C., Nakayama G., Koike M., Kodera Y. A Possible Defnition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes. Anticancer Res. 2021; 41(8): 3933–40. doi:10.21873/anticanres.15189.; Satoi S., Yamamoto T., Hashimoto D., Yamaki S., Matsui Y., Ikeura T., Boku S., Shibata N., Tsybulskyi D., Sekimoto M. Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study. J Gastrointest Oncol. 2023; 14(6): 2587–99. doi:10.21037/jgo-23-655.; Ushida Y., Inoue Y., Oba A., Mie T., Ito H., Ono Y., Sato T., Ozaka M., Sasaki T., Saiura A., Sasahira N., Takahashi Y. Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modifed FOLFIRINOX or Gemcitabine Plus Nabpaclitaxel: A Single-Center Retrospective Study. Ann Surg Oncol. 2022; 29(8): 5038–50. doi:10.1245/s10434-022-11503-6.; Hamad A., Underhill J., Ansari A., Thayaparan V., Cloyd J.M., Li Y., Pawlik T.M., Tsung A., Abushahin L., Ejaz A. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database. Surgery. 2022; 171(6): 1464–70. doi:10.1016/j.surg.2021.12.029.; Tanaka M., Heckler M., Mihaljevic A.L., Sun H., Klaiber U., Heger U., Büchler M.W., Hackert T. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX. Eur J Surg Oncol. 2019; 45(8): 1453–9. doi:10.1016/j.ejso.2019.03.039.; De Simoni O., Scarpa M., Tonello M., Pilati P., Tolin F., Spolverato Y., Gruppo M. Oligometastatic Pancreatic Cancer to the Liver in the Era of Neoadjuvant Chemotherapy: Which Role for Conversion Surgery? A Systematic Review and MetaAnalysis. Cancers (Basel). 2020; 12(11): 3402. doi:10.3390/cancers12113402.; Schwarz C., Fitschek F., Primavesi F., Stättner S., Margonis G.A., Weiss M.A., Stavrou G.A., Oldhafer K.J., Kornprat P., Wundsam H., Fischer I., Längle F., Függer R., Hauer A., Klug R., Kieler M., Prager G., Schindl M., Stremitzer S., Bodingbauer M., Sahora K., Kaczirek K. Metachronous hepatic resection for liver only pancreatic metastases. Surg Oncol. 2020; 35: 169–73. doi:10.1016/j.suronc.2020.08.005.; Zhou W., Wang D., Lou W. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis. Cancer Control. 2020; 27(1): 1–7. doi:10.1177/1073274820976593.; Mitsuka Y., Yamazaki S., Yoshida N., Yan M., Higaki T., Takayama T. Time interval-based indication for liver resection of metastasis from pancreatic cancer. World J Surg Oncol. 2020; 18(1): 294. doi:10.1186/s12957-020-02058-5.; https://www.siboncoj.ru/jour/article/view/3276

  6. 6
    Academic Journal

    Source: Russian Journal of Pediatric Hematology and Oncology; Том 10, № 4 (2023); 61-68 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 10, № 4 (2023); 61-68 ; 2413-5496 ; 2311-1267

    File Description: application/pdf

    Relation: https://journal.nodgo.org/jour/article/view/1003/883; van Hilst J., de Rooij T., Bosscha K., Brinkman D.J., van Dieren S., Dijkgraaf M.G., Gerhards M.F., de Hingh I.H., Karsten T.M., Lips D.J., Luyer M.D., Busch O.R., Festen S., Besselink M.G. Dutch Pancreatic Cancer Group. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol Hepatol. 2019;4(3):199–207. doi:10.1016/S2468-1253(19)30004-4.; Poves I., Burdío F., Morató O., Iglesias M., Radosevic A., Ilzarbe L., Visa L., Grande L. Comparison of perioperative outcomes between laparoscopic and open approach for pancreatoduodenectomy: the PADULAP randomized controlled trial. Ann Surg. 2018;268(5):731–9. doi:10.1097/SLA.0000000000002893.; Lindholm E.B., Alkattan A.K., Abramson S.J., Price A.P., Heaton T.E., Balachandran V.P., La Quaglia M.P. Pancreaticoduodenectomy for pediatric and adolescent pancreatic malignancy: A single-center retrospective analysis. J Pediatr Surg. 2017;52(2):299–303. doi:10.1016/j.jpedsurg.2016.11.025.; d’Ambrosio G., del Prete L., Grimaldi C., Bertocchini A., Lo Zupone C., Monti L., de Ville de Goyet J. Pancreaticoduodenectomy for malignancies in children. J Pediatr Surg. 2014;49:534–8. doi:10.1016/j.jpedsurg.2013.09.010.; Ortiz R., Dominguez E., Barrena S., Martinez L., Prieto G., Burgos E., Tovar J.A. Cephalic pancreaticoduodenectomy for bleeding duodenal arteriovenous malformation. Eur J Pediatr Surg Rep. 2014;2(1):13–5. doi:10.1055/s-0033-1357263.; Jones R.E., Zagory J.A., Tatum M., Tsui W.S., Murphy J. A retrospective analysis of pancreas operations in children. Transl Gastroenterol Hepatol. 2021;6:39. doi:10.21037/tgh-20-260.; Pokorny W.J., Brandt M.L., Harberg F.J. Major duodenal injuries in children: diagnosis, operative management, and outcome. J Pediatr Surg. 1986;21(7):613–6. doi:10.1016/s0022-3468(86)80416-x.; Ohata R., Okazaki T., Ishizaki Y., Fujimura J., Shimizu T., Lane G.J., Yamataka A., Kawasaki S. Pancreaticoduodenectomy for pancreatoblastoma: a case report and literature review. Pediatr Surg Int. 2010;26:447–50. doi:10.1007/s00383-010-2561-1.; Varshney A., Dhua A.K., Jain V., Agarwala S., Bhatnagar V. Whipple’s Pancreaticoduodenectomy in Pediatric Patients: An Experience from a Tertiary Care Center. J Indian Assoc Pediatr Surg. 2018;23(4):212–5. doi:10.4103/jiaps.JIAPS_35_18.; Рыбакова Д.В., Керимов П.А., Подлужный Д.В., Патютко Ю.И., Рубанский М.А., Темный А.С., Петраш Е.А., Варфоломеева С.Р., Стилиди И.С. Возможность выполнения гастро/панкреатодуоденальной резекции у детей с опухолями поджелудочной железы. Педиатрия. Журнал им. Г.Н. Сперанского. 2023;102(3):65–70. doi:10.24110/0031-403X-2023-102-3-65-70.; Richards M.K., Clifton M.S. Minimally invasive surgery of the pancreas: a narrative review of current practice. Transl Gastroenterol Hepatol. 2021;6:38. doi:10.21037/tgh-20-220.; Каминский М.Н., Качалов С.Н., Иванов Д.В., Рахимова С.Н. Гастростаз после панкреатодуоденальной резекции: вопросы терминологии и профилактики. Анналы хирургической гепатологии. 2022;27(3):100–7.; Palanivelu C., Senthilnathan P., Sabnis S.C., Babu N.S., Srivatsan Gurumurthy S., Anand Vijai N., Nalankilli V.P., Praveen Raj P., Parthasarathy R., Rajapandian S. Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. Br J Surg. 2017;104(11):1443–50. doi:10.1002/bjs.10662.; Кулевич Б.О., Разумовский А.Ю., Холостова В.В., Митупов З.Б., Хавкин А.И., Задвернюк А.С., Чумакова Г.Ю., Гордеева Е.А., Аманова М.А. Опыт выполнения панкреатодуоденальной резекции у детей. Экспериментальная и клиническая гастроэнтерология. 2022;(1):56–61. doi:10.31146/1682-8658-ecg-197-1-56-61.; Tyutyunnik P., Klompmaker S., Lombardo C., Lapshyn H., Menonna F., Napoli N., Wellner U., Izrailov R., Baychorov M., Besselink M.G., Abu Hilal M., Fingerhut A., Boggi U., Keck T., Khatkov I.; European Consortium on Minimally Invasive Pancreatic Surgery. Learning curve of three European centers in laparoscopic, hybrid laparoscopic, and robotic pancreatoduodenectomy. Surg Endosc. 2022;36(2):1515–26. doi:10.1007/s00464-021-08439-5.; Tian F., Wang Y.Z., Hua S.R., Liu Q.F., Guo J.C. Laparoscopic assisted pancreaticoduodenectomy: an important link in the process of transition from open to total laparoscopic pancreaticoduodenectomy. BMC Surg. 2020;20(1):89. doi:10.1186/s12893-020-00752-5.; Шабунин А.В., Тавобилов М.М. Выбор способа формирования панкреатодигестивного анастомоза при радикальных операциях при раке головки поджелудочной железы. Вестник Волгоградского государственного медицинского университета. 2016;1(57):121–5.; Keck T., Wellner U.F., Bahra M., Klein F., Sick O., Niedergethmann M., Wilhelm T.J., Farkas S.A., Börner T., Bruns C., Kleespies A., Kleeff J., Mihaljevic A.L., Uhl W., Chromik A., Fendrich V., Heeger K., Padberg W., Hecker A., Neumann U.P., Junge K., Kalff J.C., Glowka T.R., Werner J., Knebel P., Piso P., Mayr M., Izbicki J., Vashist Y., Bronsert P., Bruckner T., Limprecht R., Diener M.K., Rossion I., Wegener I., Hopt U.T. Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial. Ann Surg. 2016;263(3):440–9. doi:10.1097/SLA.0000000000001240.; Hashimoto D., Chikamoto A., Ohmuraya M., Hirota M., Baba H. Pancreaticodigestive anastomosis and the postoperative management strategies to prevent postoperative pancreatic fi stula formation after pancreaticoduodenectomy. Surg Today. 2014;44(7):1207–13. doi:10.1007/s00595-013-0662-x.; Malgras B., Duron S., Gaujoux S., Dokmak S., Aussilhou B., Rebours V., Palazzo M., Belghiti J., Sauvanet A. Early biliary complications following pancreaticoduodenectomy: prevalence and risk factors. HPB (Oxford). 2016;18(4):367–74. doi:10.1016/j.hpb.2015.10.012.; Райн В.Ю., Кислицин Д.П., Чернов А.А., Букирь В.В. Ранние билиарные осложнения панкреатодуоденальной резекции. Анналы хирургической гепатологии. 2021;26(4):114–9. doi:10.16931/1995-5464.2021-4-114-119.; Azeemuddin M., Al Qamari T.N., Chaudhry M.B.H., Hamid S., Hasan M., Sayani R. Percutaneous management of biliary enteric anastomotic strictures: an institutional review. Cureus. 2018;10(2):e2228. doi:10.7759/cureus.2228.; Qiu J., Li M., Du C. Antecolic reconstruction is associated with a lower incidence of delayed gastric emptying compared to retrocolic technique after Whipple or pylorus-preserving pancreaticoduodenectomy. Medicine (Baltimore). 2019;98(34):e16663. doi:10.1097/MD.0000000000016663.; Camilleri M., Parkman H.P., Shafi M.A., Abell T.L., Gerson L. American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37; quiz 38. doi:10.1038/ajg.2012.373.; Warshaw A.L., Torchiana D.L. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. Surg Gynecol Obstet. 1985;160(1):1–4. PMID: 3964962.; Wu W., Hong X., Fu L., Liu S., You L., Zhou L., Zhao Y. The eff ect of pylorus removal on delayed gastric emptying after pancreaticoduodenectomy: a meta-analysis of 2,599 patients. PLoS One. 2014;9(10):e108380. doi:10.1371/journal.pone.0108380.; Zhou Y., Lin L., Wu L., Xu D., Li B. A case-matched comparison and meta-analysis comparing pylorus-resecting pancreaticoduodenectomy with pylorus-preserving pancreatico-duodenectomy for the incidence of postoperative delayed gastric emptying. HPB (Oxford). 2015;17(4):337–43. doi:10.1111/hpb.12358.; Tomomasa T., Kuroume T., Arai H., Wakabayashi K., Itoh Z. Erythromycin induces migrating motor complex in human gastro intestinal tract. Dig Dis Sci. 1986;31(2):157–61. doi:10.1007/BF01300701.; Costalos C., Gounaris A., Varhalama E., Kokori F., Alexiou N., Kolovou E. Erythromycin as a prokinetic agent in preterm infants. J Pediatr Gastroenterol Nutr. 2002;34:23–5. doi:10.1097/00005176-200201000-00006.; Lunding J.A., Nordström L.M., Haukelid A.O., Gilja O.H., Berstad A., Hausken T. Vagal activation by sham feeding improves gastric motility in functional dyspepsia. Neurogastroenterol Motil. 2008;20:618–24. doi:10.1111/j.1365-2982.2007.01076.x.; Saliakellis E., Fotoulaki M. Gastroparesis in children. Ann Gastroenterol. 2013;26(3):204–11. PMID: 24714281.; Sakamoto Y., Kato S., Sekino Y., Sakai E., Uchiyama T., Iida H., Hosono K., Endo H., Fujita K., Koide T., Takahashi H., Yoneda M., Tokoro C., Goto A., Abe Y., Kobayashi N., Kubota K., Maeda S., Nakajima A., Inamori M. Change of gastric emptying with chewing gum: evaluation using a continuous real-time C breath test (BreathID system). J Neurogastroenterol Motil. 2011;17(2):174–9. doi:10.5056/jnm.2011.17.2.174.; Andersson T., Bjerså K., Falk K., Olsén M.F. Eff ects of chewing gum against postoperative ileus after pancreaticoduodenectomy – a randomized controlled trial. BMC Res Notes. 2015;8:37. doi:10.1186/s13104-015-0996-0.; Arima J., Taniguchi K., Kobayashi T., Tsunematsu I., Kagota S., Sakane J., Suzuki Y., Uchiyama K., Hiramatsu M. Systemic steroid application for treatment of edematous anastomotic stenosis following delta-shaped anastomosis in laparoscopic distal gastrectomy: a case report. BMC Surg. 2020;20(1):163. doi:10.1186/s12893-020-00827-3.; Kang L.H., Brown C.N. Pediatric Biliary Interventions in the Native Liver. Semin Intervent Radiol. 2016;33(4):313–23. doi:10.1055/s-0036-1592323.; Sheng Q., Lv Z., Xu W., Xiao X., Liu J., Wu Y. Reoperation After Cyst Excision with Hepaticojejunostomy for Choledochal Cysts: Our Experience in 18 Cases. Med Sci Monit. 2017;23:1371–7. doi:10.1055/s-0036-1592323.; Акинфиев Д.М., Бахмутова Е.Е., Беляков Г.А., Вишневский В.А., Гурченкова Е.Ю., Давыдова С.В., Демидова В.С., Дубова Е.А., Зеленов М.А., Израилов Р.Е., Кармазановский Г.Г., Климов А.Е., Коков Л.С., Кокова Н.И., Кулезнева Ю.В., Осипова Н.Ю., Скруберт В.С., Степанова Ю.А., Тарбаева Н.В., Титова М.И., Фёдоров А.Г., Цвиркун В.В., Цыганков В.Н., Черная Н.Р., Шевченко Т.В., Шуракова А.Б., Шутихина И.В., Щёголев А.И. Лучевая диагностика и малоинвазивное лечение механической желтухи: руководство. М.: Радиология-пресс, 2010. 259 с.; Liu Y.S., Lin C.Y., Chuang M.T., Tsai Y.S., Wang C.K., Ou M.C. Success and complications of percutaneous transhepatic biliary drainage are infl uenced by liver entry segment and level of catheter placement. Abdom Radiol (NY). 2018;43(3):713–22. doi:10.1007/s00261-017-1258-5.; Racadio J.M., Kukreja K. Pediatric biliary interventions. Tech Vasc Interv Radiol. 2010;13(4):244–9. doi:10.1053/j.tvir.2010.04.007.; Kahriman G., Ozcan N., Gorkem S.B. Percutaneous management of bile duct stones in children: results of 12 cases. Diagn Interv Radiol. 2017;23(2):133–6. doi:10.5152/dir.2016.16178.; Lorenz J.M., Denison G., Funaki B., Leef J.A., Van Ha T., Rosenblum J.D. Balloon dilatation of biliary-enteric strictures in children. Am J Roentgenol. 2005;184(1):151–5. doi:10.2214/ajr.184.1.01840151.; https://journal.nodgo.org/jour/article/view/1003

  7. 7
    Academic Journal

    Contributors: 1

    Source: Almanac of Clinical Medicine; Vol 52, No 5 (2024); 249-258 ; Альманах клинической медицины; Vol 52, No 5 (2024); 249-258 ; 2587-9294 ; 2072-0505

    File Description: application/pdf

  8. 8
    Academic Journal

    Source: EMERGENCY MEDICINE; № 2.97 (2019); 94-100
    МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; № 2.97 (2019); 94-100
    МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; № 2.97 (2019); 94-100

    File Description: application/pdf

  9. 9
  10. 10
  11. 11
    Academic Journal

    Source: PAEDIATRIC SURGERY. UKRAINE; No. 1(78) (2023): Paediatric surgery (Ukraine); 88-95
    ХИРУРГИЯ ДЕТСКОГО ВОЗРАСТА; № 1(78) (2023): Paediatric surgery (Ukraine); 88-95
    Хірургія дитячого віку; № 1(78) (2023): Хірургія дитячого віку (Україна); 88-95

    File Description: application/pdf

  12. 12
  13. 13
    Academic Journal

    Source: Medicine in Kuzbass; Том 22, № 2 (2023): июнь; 36-44 ; Медицина в Кузбассе; Том 22, № 2 (2023): июнь; 36-44 ; 2588-0411 ; 1819-0901

    File Description: text/html; application/pdf

  14. 14
  15. 15
  16. 16
  17. 17
    Academic Journal

    Source: Сборник статей

    File Description: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: Материалы VI Международной научно-практической конференции молодых учёных и студентов, посвященной году науки и технологий, (Екатеринбург, 8-9 апреля 2021): в 3-х т.; http://elib.usma.ru/handle/usma/6097

  18. 18
    Academic Journal

    Source: Siberian journal of oncology; Том 20, № 2 (2021); 136-140 ; Сибирский онкологический журнал; Том 20, № 2 (2021); 136-140 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2021-20-2

    File Description: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/1766/857; Balci B., Calik B., Karadeniz T., Sahin H., Ugurlu L., Aydin C. Primary squamous cell carcinoma of the ampulla of Vater: a case report. Surg Case Rep. 2016 Dec; 2(1): 2. doi:10.1186/s40792-016-0130-0.; Hoshimoto S., Aiura K., Shito M., Kakefuda T., Sugiura H. Adenosquamous carcinoma of the ampulla of Vater: a case report and literature review. World J Surg Oncol. 2015 Sep 29; 13: 287. doi:10.1186/s12957-015-0709-0.; Arita K., Masuda T., Tanaka H., Kubochi M., Moriya Y., Fukumoto K., Shinobi T., Yoshino H., Ishizu H. An autopsy case report of adenosquamous cell carcinoma of the duodenal papilla with multiple liver and lung metastases. Nihon Shokakibyo Gakkai Zasshi. 2013 Sep; 110(9): 1649–56.; Sunose Y., Ogawa T., Itoh H., Andoh T., Tomizawa N., Tanaka T., Sakamoto I., Arakawa K., Ikeya T., Takeyoshi I. Large cell neuroendocrine carcinoma of the ampulla of vater with adenocarcinoma and squamous cell carcinoma components. Jpn J Clin Oncol. 2011; 41(3): 434–9. doi:10.1093/jjco/hyq186.; Albores-Saavedra J., Hart A., Chablé-Montero F., Henson D.E. Carcinoids and high-grade neuroendocrine carcinomas of the ampulla of vater: a comparative analysis of 139 cases from the surveillance, epidemiology, and end results program-a population based study. Arch Pathol Lab Med. 2010 Nov; 134(11): 1692–6. doi:10.1043/2009-0697-OAR.1.; Albores-Saavedra J., Henson D.E., Klimstra D. Malignant epithelial tumors of the ampulla. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. Atlas of Tumor Pathology. Armed Forces Institute of Pathology. Washington DC. 2000; 290–293 p.; Карпов О.Э., Маады А.С., Алексеев К.И., Левчук А.Л., Степанюк И.В., Плотницкий А.В., Судиловская В.В. Нейроэндокринная опухоль большого дуоденального сосочка. Вестник Национального медико-хирургического Центра им. Н.И. Пирогова. 2014; 9(4): 125–127.; Sugawara G., Yamaguchi A., Isogai M., Watanabe Y., Kaneoka Y., Suzuki M. Small cell neuroendocrine carcinoma of the ampulla of Vater with foci of squamous differentiation: a case report. J Hepatobiliary Pancreat Surg. 2004; 11(1): 56–60. doi:10.1007/s00534-002-0840-5.; Поддубная И.В., Каприн А.Д., Лядов В.К. Классификация опухолей TNM. 8-я редакция. Руководство и атлас. Том I: Опухоли торако-абдоминальной локализации. М., 2019. 424 с.; Орел Н.Ф., Артамонова Е.В., Горбунова В.А., Делекторская В.В., Емельянова Г.С., Любимова Н.В., Маркович А.А., Орлова К.В., Орлова Р.В., Трифанов В.С. Практические рекомендации по лекарственному лечению нейроэндокринных опухолей желудочнокишечного тракта, поджелудочной железы и других локализаций. Злокачественные опухоли. Практические рекомендации RUSSCO. 2019; #3s2 (9): 486–497.; Bolanaki H., Giatromanolaki A., Sivridis E., Karayiannakis A.J. Primary squamous cell carcinoma of the ampulla of Vater. JOP. 2014 Jan; 15(1): 42–5. doi:10.6092/1590-8577/1649. PMID: 24413783.; Selvakumar E., Rajendran S., Balachandar T.G., Kannan D.G., Jeswanth S., Ravichandran P., Surendran R. Neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic evaluation. Hepatobiliary Pancreat Dis Int. 2008 Aug; 7(4): 422–5.; Suzuki S., Tanaka S., Hayashi T., Harada N., Suzuki M., Hanyu F., Ban S. Small-cell neuroendocrine carcinoma of the ampulla of Vater. J Hepatobiliary Pancreat Surg. 2006; 13(5): 450–3. doi:10.1007/s00534-005-1093-x.; Liu S.H., Tsay S.H. Coexistence of large cell neuroendocrine carcinoma and adenocarcinoma of the ampulla of vater. J Chin Med Assoc. 2008 Oct; 71(10): 536–40. doi:10.1016/S1726-4901(08)70164-3.; Sato T., Yamamoto K., Ouchi A., Imaoka Y., Tokumura H., Matsushiro T. Undifferentiated carcinoma of the duodenal ampulla. J Gastroenterol. 1995 Aug; 30(4): 517–9. doi:10.1007/BF02347570.; Yamamoto Y., Watanabe Y., Horiuchi A., Yoshida M., Yukumi S., Sato K., Nakagawa H., Sugishita H., Ishida N., Ishikawa M., Ishikawa K., Kawachi K. Adenoendocrine carcinoma of the accessory papilla of the duodenum: report of a case. Surg Today. 2009; 39(5): 425–9. doi:10.1007/s00595-008-3874-8.; https://www.siboncoj.ru/jour/article/view/1766

  19. 19
    Academic Journal

    Source: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 10, № 3 (2021); 469-476 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 10, № 3 (2021); 469-476 ; 2541-8017 ; 2223-9022

    File Description: application/pdf

    Relation: https://www.jnmp.ru/jour/article/view/1208/971; https://www.jnmp.ru/jour/article/view/1208/1062; Чиссов В.И., Трахтенберг А.Х., Пачес А.И. (ред.) Атлас онкологических операций. Москва: ГЭОТАР-Медиа; 2008.; Хатьков И.Е., Цвиркун В.В., Израилов Р.Е., Михневич М.В. Хирургический этап лечения рака органов гепатопанкреатодуоденальной зоны традиционным, лапароскопическим и робот-ассистированным способом: результаты, преимущества, недостатки. Анналы хирургической гепатологии. 2019; 24(3):54–72. https://doi.org/10.16931/1995-5464.2019354-64; Федоров В.Д., Буриев И.М., Икрамов Р.З. Хирургическая панкреатология: руководство для врачей. Москва: Медицина; 1999.; Щастный А.Т. Послеоперационные осложнения проксимальных резекций поджелудочной железы у пациентов с хроническим панкреатитом. Новости хирургии. 2011;19(3):30–43.; Оноприев В.И., Коротько Г.Ф., Рогаль М.Л., Восканян С.Э.Панкреатодуоденальная резекция (аспекты хирургической техники, функциональные последствия). Краснодар; 2005.; Late Sequelae of COVID-19. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. November 13, 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/late-sequelae.html [Accessed 20.02.2021].; Perico L, Benigni A, Casiraghi F, Ng L, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nature reviews. Nephrology. 2021;17(1):46–64. https://doi.org/10.1038/s41581-020-00357-4; Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 8 от 03.09.2020. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/777/original/030902020_COVID-19_v8.pdf (Дата обращения 20.02.2021.); Ho CK, Kleeff J, Friess H, Büchler MW. Complications of pancreatic surgery. HPB (Oxford). 2005;7(2):99–108. https://doi.org/10.1080/13651820510028936; Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, et al. Predicting the risks of venous thromboembolism versus postpancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford). 2014;16(4):373–83. https://doi.org/10.1111/hpb.12148; Teshome MK, Najib K, Nwagbara CC, Akinseye OA, Ibebuogu UN. Patent Foramen Ovale: A Comprehensive Review. Curr Probl Cardiol. 2020;45(2):100392. https://doi.org/10.1016/j.cpcardiol.2018.08.004; Müller S, Beyer-Westendorf J. Thromboembolic Complications in COVID-19. Dtsch Med Wochenschr. 2020;145(24):1728–1734. https://doi.org/10.1055/a-1198-3639; Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells. 2020;9(7):1652. https://doi.org/10.3390/cells9071652; Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120. https://doi.org/10.1186/s13045-020-00954-7; Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020;46(6):1105–1108. https://doi.org/10.1007/s00134-020-06059-6; Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, et al. Covid-19: The Rollercoaster of Fibrin (Ogen), DDimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int J Mol Sci. 2020;21(14):5168. https://doi.org/10.3390/ijms21145168; Gavriilaki E, Brodsky RA. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol. 2020;189(6):e227-e230. https://doi.org/10.1111/bjh.16783; Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):360. https://doi.org/ 10.1186/s13054-020-03077-0; Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581–589. https://doi.org/ 10.1038/s41584-020-0474-5; https://www.jnmp.ru/jour/article/view/1208

  20. 20